# US 2026/0091056 A1 · Compositions for controlling odor and itch and methods of and devices for administering same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0091056 A1
- Document ID: US20260091056A1
- Status: Published application
- Kind: A1
- Application number: 19/413,496
- Filed: 2025-12-09
- Published: 2026-04-02
- Earliest claimed: 2020-06-30
- Assignees: Vireo Systems, Inc.
- Applicants: Vireo Systems, Inc.
- Inventors: Mark C. Faulkner; Deeannah Seymour
- Web page: https://patentgrep.com/patent/US20260091056A1

## CPC

- A61K 33/22: Boron compounds
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61K 9/10: Dispersions; Emulsions
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 15/02: for disorders of the vagina
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compositions, such as aqueous solutions and non-aqueous solutions and slurries, of a weak acid are provided. The disclosed compositions may be used to treat, prevent, and/or reduce one or more symptoms associated with numerous vaginal conditions or disturbances, such as odor and itch.

## Claims

### Claim 1

A method of reducing at least one of vaginal odor or itch in a subject in need thereof, comprising:
administering a formulation to a vagina of the subject, wherein the formulation consists of boric acid in a powder form and a dissolvable base, and
wherein the formulation has a melting temperature of about 36° C. to about 38° C. and the formulation releases the boric acid upon exposure to the vagina.

### Claim 2 (depends on 1)

The method of claim 1, wherein the boric acid is present in the formulation in an amount of about 500 mg to about 700 mg.

### Claim 3 (depends on 1)

The method of claim 1, wherein the dissolvable base is a gelatin base.

### Claim 4 (depends on 1)

The method of claim 1, wherein the subject is a human.

### Claim 5 (depends on 1)

The method of claim 1, wherein, upon administration of the formulation to the vagina, the subject experiences a negative whiff test within about 24 hours or less.

### Claim 6 (depends on 1)

The method of claim 1, wherein the formulation is a vaginal capsule or vaginal suppository.

### Claim 7

A method of reducing at least one of vaginal odor or itch in a subject in need thereof, comprising:
administering a suppository to a vagina of the subject, wherein the suppository consists of boric acid in an amount of about 500 mg to about 700 mg, a moisturizing agent, an antioxidant, and a dissolvable base,
wherein the suppository has a melting temperature of about 36° C. to about 38° C. and the suppository releases the boric acid upon exposure to the vagina, and
wherein, upon administration of the suppository, the subject experiences a negative whiff test within about 24 hours or less.

### Claim 8 (depends on 7)

The method of claim 7, wherein the boric acid is in a powder form.

### Claim 9 (depends on 7)

The method of claim 7, wherein the moisturizing agent is coconut oil.

### Claim 10 (depends on 7)

The method of claim 7, wherein the antioxidant is selected from the group consisting of vitamin E, vitamin A, vitamin C, hyaluronic acid, collagen, glucosamine sulfate, chondroitin sulfate, alpha-lipoic acid, and combinations thereof.

### Claim 11 (depends on 7)

The method of claim 7, wherein the antioxidant is selected from the group consisting of vitamin E, vitamin C, and combinations thereof.

### Claim 12 (depends on 7)

The method of claim 7, wherein the dissolvable base is a gelatin base.

### Claim 13 (depends on 7)

The method of claim 7, wherein the suppository is administered up to four times per week.

### Claim 14 (depends on 7)

The method of claim 7, wherein the moisturizing agent is coconut oil and the antioxidant is vitamin E.

### Claim 15 (depends on 7)

The method of claim 7, wherein, upon administration of the suppository, the subject experiences a negative whiff test within about 12 hours or less.

### Claim 16

A method of neutralizing odor in a subject in need thereof, comprising:
administering a formulation to an external area of the subject, wherein the formulation is an aqueous solution comprising water, boric acid, citric acid, ascorbic acid, and lactic acid.

### Claim 17 (depends on 16)

The method of claim 16, wherein the boric acid is present in the aqueous solution in an amount of about 1 mg/mL to about 12 mg/mL.

### Claim 18 (depends on 16)

The method of claim 16, wherein the aqueous solution has a pH of about 2 to about 7 at about 20° C.

### Claim 19 (depends on 16)

The method of claim 16, wherein the formulation is administered to the external area on a daily basis.

### Claim 20 (depends on 16)

The method of claim 16, wherein the boric acid is present in the aqueous solution in an amount of about 4 mg/mL to about 9 mg/mL.
